News
Financial year 2021/22: Sonova delivers solid results and significantly advances its growth strategy
Update on the timeline for Vifor Pharma tender offer
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to
Update zum Zeitplan des öffentlichen Kaufangebots für Vifor Pharma
Regulatory News:
CSL Limited (ASX: CSL; USOTC:CSLLY) hat gestern ein Update bezüglich der Übernahme der Vifor Pharma AG veröffentlicht. CSL hat zuvor mitgeteilt, dass das Unternehmen die
SFS completes transaction with Hoffmann
Jonas Van Holanda is the winner of the 2022 Helvetia Art Prize
Dufry wins two new six-year duty-free and duty-paid contracts at Salvador International Airport in Brazil
Baloise supports young curators at Art Forum Baloise Park
PSP Swiss Property with a successful Q1 2022. Improved ebitda guidance.
Baloise Group reports a robust SST ratio of 220 per cent
Annual General Meeting of Bâloise Holding Ltd: shareholders vote in favour of the proposals by the Board of Directors
Shareholders' Meeting elects Thomas Schmuckli as Chairman of the Board of Directors
Helvetia with an excellent SST ratio of 260%
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
Straumann Group reports very strong first quarter
SFS shareholders approve all proposals at the Annual General Meeting
Continued sales growth despite mounting challenges
94th Vifor Pharma Group Annual General Meeting
Regulatory News:
At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was
94. Generalversammlung der Vifor Pharma Gruppe
Regulatory News:
An der heutigen 94. ordentlichen Generalversammlung der Vifor Pharma AG haben die Aktionäre alle Anträge des Verwaltungsrats genehmigt. Die Generalversammlung fand erneut